AstraZeneca PLC - Other Cashflows From Financing Activities
AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.The Serie's long term average value is 3.06 Billion United States Dollars. It's latest available value, on 09/30/2025, is -3.15 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +2.46 Billion.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2012, to it's latest available value, on 09/30/2025, is -12.42 Billion.
Other Cashflows From Financing Activities for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Other Cashflows From Financing Activities | 905,699,262,464.00 |
 | Johnson & Johnson - Other Cashflows From Financing Activities | 486,508,953,600.00 |
 | AbbVie Inc - Other Cashflows From Financing Activities | 399,570,305,024.00 |
 | Roche Holding AG - Other Cashflows From Financing Activities | 317,433,206,677.55 |
 | Novartis AG - Other Cashflows From Financing Activities | 255,096,620,580.91 |